GLP1R Protein, Human, Recombinant (hFc Tag)

1/1
Price:
Size:
Number:

GLP1R Protein, Human, Recombinant (hFc Tag): Product Information

Purity
> 95 % as determined by SDS-PAGE.
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
Activity
Testing in progress
Protein Construction
A DNA sequence encoding the human GLP1R (NP_002053.3) (Met1-Tyr145) was expressed with the Fc region of human IgG1 at the C-terminus.
Accession#
Expressed Host
HEK293 Cells
Species
Human
Predicted N Terminal
Arg 24
Molecule Mass
The recombinant human GLP1R consists 363 amino acids and predicts a molecular mass of 41.3 kDa.
Formulation
Lyophilized from sterile PBS, pH 7.4.
Please contact us for any concerns or special requirements.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

GLP1R Protein, Human, Recombinant (hFc Tag): Images

GLP1R Background Information

Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. GLP1R plays a critical role in mediating the biological actions of GLP1 in mammals and fish. The neuronal GLP1Rs mediate body weight and anorectic effects of liraglutide, but are not required for glucose-lowering effects. Glucagon-like peptide 1 receptor (GLP1R) signaling has been shown to have antipsychotic properties in animal models and to impact glucose-dependent insulin release, satiety, memory, and learning in man. Glucagon-like peptide-1 receptor (GLP1R) and glucose-dependent insulinotropic peptide receptor (GIPR) are their indirect drug targets.
Full Name
glucagon-like peptide 1 receptor
  • Prolonged half-life of small-sized therapeutic protein using serum albumin-specific protein binder
    Author
    Kim, TY;Park, JH;Shim, HE;Choi, DS;Lee, DE;Song, JJ;Kim, HS;
    Year
    2019
    Journal
    J Control Release
Add to Cart Successfully Add to Cart Failed Shopping cart is being updated, please wait U.S.A.